Vall d'Hebron involved in the development of a new treatment for hereditary angioedema

by Vall d’Hebron

It is a rare genetic disease that can cause death of patients. It affects approximately one person between 10,000-50,000. It is caused by the lack of C1 esterase inhibitor, which regulates the contact...

Read more

A new way of assessing microcephaly in the context of the Zika virus epidemic

by ISGlobal - Instituto de Salud Global de Barcelona

​An international team led by Clara Menendez, director of the Maternal, Child and Reproductive Health Initiative at ISGlobal, describes a new way of defining microcephaly based on the ratio between ...

Read more

La Paz investiga el origen autoinmune de algunas lipodistrofias

by Hospital Universitario La Paz

Investigadores del Hospital Universitario La Paz-IdiPAZ y del Hospital Clínico Universitario de Santiago trabajan juntos en la búsqueda de mecanismos para un diagnóstico rápido de las lipodistrofi...

Read more

Zika will have a long-term impact and will disproportionately affect the poorest in Latin America and the Caribbean

by ISGlobal - Instituto de Salud Global de Barcelona

The report concludes that the preparedness and response strategies need to be reinforced, and the communities must be involved. It provides a list of six recommendations, including integrated strategi...

Read more

Mutaciones en uno de los genes asociados con la inmunodeficiencia severa combinada producen además acortamiento telomérico

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

Investigadores de diversos grupos del CIBERER han colaborado en una investigación liderada por la Dra. Rosario Perona, jefa de grupo de la U757 en el Instituto de Investigaciones Biomédicas Alberto ...

Read more

Determinan el origen y expansión de la fascioliasis humana en América del Sur

by Universitat de València

La Unidad de Parasitología Humana de la Universitat de València en colaboración con investigadores uruguayos ha determinado el origen y expansión en Sudamérica de la fascioliasis, una enfermedad ...

Read more

Una jornada aborda la transición de la etapa infantil a la adulta en mucopolisacaridosis

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

El Grupo multidisciplinar Sumando de atención a pacientes con mucopolisacaridosis (MPS) y otras enfermedades neurodegenerativas organiza la tercera edición de su reunión, dedicada en esta ocasión ...

Read more

A study validates the combination of two rapid tests for Chagas Disease diagnosis

by ISGlobal - Instituto de Salud Global de Barcelona

A study led by ISGlobal and performed in Bolivia in collaboration with CEADES, the Universidad Andina and the Health Department of Chuquisaca, validates the parallel use of two rapid diagnostic tests ...

Read more

A Brazilian pharmaceutical company takes a key step towards ending yaws for good

by ISGlobal - Instituto de Salud Global de Barcelona

Azythromycine is a cheap, effective and easy-to-administer antibiotic. In 2012, a ISGlobal team led by Oriol Mitjá and Quique Bassat demonstrated, for the first time, that one single oral dose of the...

Read more

A cellular model to help study the relationship between neurodegenerative diseases

by Institut de Bioenginyeria de Catalunya

From the cells of a patient with a rare neurodegenerative disease, Gerstmann-Sträussler-Scheinker syndrome (GSS), researchers at IBEC have managed to generate neurons that also present parallel neuro...

Read more

A dysfunction in the chloride channel in astrocytes, involved in megalencephalic leukoencephalotaphy

by Universitat de Barcelona

A research study led by researchers of the University of Barcelona and published in the journal Human Molecular Genetics, has provided a better understanding of a physiopathological process in astrocy...

Read more

Realizan el estudio molecular más completo en España de una enfermedad rara con alta incidencia en niños de etnia gitana

by Universidad de Granada

Un equipo de científicos liderados por la Universidad de Granada (UGR) ha realizado el estudio molecular más completo realizado hasta la fecha sobre pacientes españoles con Ataxia-Telangiectasia (A...

Read more
Subscribe to Directory
Write an Article

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A study suggests that epigenetic treatme...

by Instituto de Investigación Biomédica ( IRB Barcelona )

A team headed by ICREA researchers Salvador Aznar Benitah and Fran Sup...

Photos Stream